STEVEN GROSSMAN 12/21/18 STEVEN GROSSMAN 12/21/18 What Happens At and After Midnight, Cinderella? Read More Advocacy at a Glance STEVEN GROSSMAN 12/15/17 Advocacy at a Glance STEVEN GROSSMAN 12/15/17 CR Expires December 22; No Clear Path to Completion and more Read More Analysis and Commentary STEVEN GROSSMAN 12/1/17 Analysis and Commentary STEVEN GROSSMAN 12/1/17 No One’s Interests Would Be Served by a Shutdown Read More Analysis and Commentary STEVEN GROSSMAN 12/5/16 Analysis and Commentary STEVEN GROSSMAN 12/5/16 21st Century Cures Passes House -- with Pros and Cons Read More
STEVEN GROSSMAN 12/21/18 STEVEN GROSSMAN 12/21/18 What Happens At and After Midnight, Cinderella? Read More
Advocacy at a Glance STEVEN GROSSMAN 12/15/17 Advocacy at a Glance STEVEN GROSSMAN 12/15/17 CR Expires December 22; No Clear Path to Completion and more Read More
Analysis and Commentary STEVEN GROSSMAN 12/1/17 Analysis and Commentary STEVEN GROSSMAN 12/1/17 No One’s Interests Would Be Served by a Shutdown Read More
Analysis and Commentary STEVEN GROSSMAN 12/5/16 Analysis and Commentary STEVEN GROSSMAN 12/5/16 21st Century Cures Passes House -- with Pros and Cons Read More
